Why are some early-phase investigational drugs missing targets?

In early-phase studies, capturing specific targets can be challenging. 

Known Issues

It's common in early phases for drug descriptions to be left blank. This happens because the data is still preliminary and the research hasn't yet fully defined the parameters or characteristics of the investigational drugs.

Workaround

Enable the AI Journal Reader in the Table Builder for expanded insights. The Journal Reader pulls data from PubMed using our proprietary AI, which is created and supported by our data team. 

To add Journal Reader data to your table:

• Toggle the Journal Reader on in the top right corner of the Table Builder

• Add filters with Journal Reader data, marked by a ✨

Note: If you need more specific information we can provide quantification details upon request.

Got a minute to help us improve? 

We value your experience and are eager to hear your thoughts. Whether it’s a hiccup or a suggestion, your feedback is a vital part of this development process. Send us feedback.